Page last updated: 2024-10-29

ketoconazole and Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

ketoconazole has been researched along with Precursor B-Cell Lymphoblastic Leukemia-Lymphoma in 1 studies

1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma: A leukemia/lymphoma found predominately in children and adolescents and characterized by a high number of lymphoblasts and solid tumor lesions. Frequent sites involve LYMPH NODES, skin, and bones. It most commonly presents as leukemia.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Moore, L1
Ellis, DH1
Suppiah, R1
Byard, RW1
Toogood, IR1

Other Studies

1 other study available for ketoconazole and Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

ArticleYear
Complete eradication of Aspergillus fumigatus from the lung in an immunocompromised patient by oral itraconazole.
    Journal of paediatrics and child health, 1993, Volume: 29, Issue:2

    Topics: Administration, Oral; Adolescent; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols;

1993